1. Regulation (EC) No. 141/2000 of the European parliament and of the council of 16 December 1999 on orphan medicinal products. Official Journal of the European Communities 2000;L18:1–5. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:en:PDF. [Accessed 22 February 2017].
2. European Medicine Agency. Rare disease (orphan) designations. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/orphan_search.jsp. [Accessed 22 February 2017].
3. Access to orphan drugs in Europe: current and future issues;Michel;Expert Review of Pharmacoeconomics & Outcomes Research,2012
4. Access to orphan drugs: a comprehensive review of legislations, regulations and policies in 35 countries;Gammie;PLoS One,2015
5. Negotiating prices of drugs for rare diseases;Henrard;Bulletin of the World Health Organization,2016